Related Experiment Videos
Prognostic factors in renal cell carcinoma
A Usubütün1, A Ayhan, M C Uygur
1Hacettepe University, Faculty of Medicine, Dept. of Pathology and Urology, Ankara, Turkey.
Summary
Tumor stage, necrotic areas, and growth patterns significantly impact renal cell carcinoma (RCC) survival. However, patient age, sex, and tumor location do not affect outcomes in RCC prognosis.
Area of Science:
- Oncology
- Pathology
Background:
- Renal cell carcinoma (RCC) is a significant cause of cancer-related mortality.
- Identifying accurate prognostic factors is crucial for effective patient management and treatment strategies.
Purpose of the Study:
- To evaluate morphological and clinical prognostic factors in patients with renal cell carcinoma (RCC).
- To determine the significance of various factors in predicting patient survival.
Main Methods:
- Retrospective analysis of 166 patients diagnosed with renal cell carcinoma (RCC).
- Evaluation of clinical data including age, sex, tumor stage, grade, and size.
- Assessment of pathological features such as tumor weight, cell type, invasion, growth pattern, and presence of necrosis.
Main Results:
- Tumor stage, particularly metastasis, was the most significant prognostic factor for RCC survival (p < 0.001).
- Tumor grade (p = 0.0146) and the presence of necrotic areas (p = 0.0102) also showed prognostic value.
- Infiltrative growth pattern was associated with poorer prognosis compared to pushing type growth pattern (p = 0.0045).
- Tumor diameter and nephrectomy specimen weight were significant prognostic indicators.
- Patient age, sex, tumor location, renal vein invasion, pseudocapsules, intravascular tumor, mitotic rate, lymphocyte/macrophage presence, and calcifications did not significantly affect survival (p > 0.05).
Conclusions:
- Tumor stage, grade, necrotic areas, and growth pattern are key prognostic indicators for renal cell carcinoma (RCC).
- Clinical factors like age and sex, and certain pathological features, do not significantly influence RCC patient survival.
- Accurate pathological assessment is vital for predicting RCC outcomes and guiding treatment decisions.